Reuters logo
BRIEF-Novartis' Zykadia wins FDA approval as initial therapy for type of lung cancer
May 26, 2017 / 8:06 PM / 4 months ago

BRIEF-Novartis' Zykadia wins FDA approval as initial therapy for type of lung cancer

May 26 (Reuters) - Novartis Ag

* Novartis receives FDA approval for expanded use of zykadia® in first-line alk-positive metastatic non-small cell lung cancer (nsclc) Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below